RSS Feed Print Category View
Simeprevir Earns Positive Internal Review from FDA
Posted: Tuesday, October 22, 2013 1:33 PM
Joined: 2/20/2013
Posts: 40

"Johnson & Johnson and its partner Medivir took another big step toward the booming hepatitis C market today, earning a positive internal review at the FDA for simeprevir. But analysts concluded that a substantial subpopulation of patients infected with a particular polymorphism variant won't likely benefit from the NS3/4A protease inhibitor, leaving that field open to some big rivals contending for near-term approvals."

To read more, please visit: